Good news: treatments have significantly increased five-year survival for CTEPH

Since the 1980s, treatment options for patients with chronic thromboembolic pulmonary hypertension (CTEPH) have increased. This study looked at whether five-year survival for CTEPH patients also improved.

The researchers looked at 834 CTEPH patients, dividing them into early (1980s and 1990s), middle (2000s), and late (2010-2023) eras.

• Early era patients received CTEPH therapy only 35% of the time, and 68% survived for five years.

• Middle era patients received therapy 64% of the time. 85% survived for five years.

• Late era patients received therapy 97% of the time, and 93% survived for five years.

Clearly, CTEPH therapies and the long-term prognosis of patients with CTEPH have improved substantially in recent decades.

Read the European Respiratory Journal paper